Molecular assay may help identify NSCLC patients who could benefit from adjuvant chemotherapy
Dr Veronesi presents about state of the art technology in imaging at the Future Horizons in Lung Cancer meeting.
Molecular assay may help identify NSCLC patients who could benefit from adjuvant chemotherapy
New classification for identifying HR myeloma based on cytogenetic abnormalities
Predicting tumour mutations from pathology images may help increase personalised medicine utilisation
SABCS 2023: Latest breast cancer diagnostics guidelines
Genomic testing: Awareness and effective communication between healthcare professionals and patients
War in Ukraine: The Global Medical Knowledge Alliance's response to improving cancer care
Liquid biopsies and cancer: The role of NGS, CTC, exosomes, cfDNA and cfRNA
Choosing Wisely in radiology Tanzania
Precision oncology: Present and future in breast cancer